Turning on a Fuel Switch of Cancer: hnRNP Proteins Regulate Alternative Splicing of Pyruvate Kinase mRNA
- 14 November 2010
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (22), 8977-8980
- https://doi.org/10.1158/0008-5472.can-10-2513
Abstract
Unlike normal cells, which metabolize glucose by oxidative phosphorylation for efficient energy production, tumor cells preferentially metabolize glucose by aerobic glycolysis, which produces less energy but facilitates the incorporation of more glycolytic metabolites into the biomass needed for rapid proliferation. The metabolic shift from oxidative phosphorylation to aerobic glycolysis is partly achieved by a switch in the splice isoforms of the glycolytic enzyme pyruvate kinase. Although normal cells express the pyruvate kinase M1 isoform (PKM1), tumor cells predominantly express the M2 isoform (PKM2). Switching from PKM1 to PKM2 promotes aerobic glycolysis and provides a selective advantage for tumor formation. The PKM1/M2 isoforms are generated through alternative splicing of two mutually exclusive exons. A recent study shows that the alternative splicing event is controlled by heterogeneous nuclear ribonucleoprotein (hnRNP) family members hnRNPA1, hnRNPA2, and polypyrimidine tract binding protein (PTB; also known as hnRNPI). These findings not only provide additional evidence that alternative splicing plays an important role in tumorigenesis, but also shed light on the molecular mechanism by which hnRNP proteins regulate cell proliferation in cancer. Cancer Res; 70(22); 8977–80. ©2010 AACR.Keywords
This publication has 27 references indexed in Scilit:
- Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cellsThe International Journal of Biochemistry & Cell Biology, 2010
- Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitroOncogene, 2007
- The gene encoding the splicing factor SF2/ASF is a proto-oncogeneNature Structural & Molecular Biology, 2007
- Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferationJournal of Cell Science, 2005
- Pyruvate kinase type M2 and its role in tumor growth and spreadingSeminars in Cancer Biology, 2005
- Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell lineOncogene, 2004
- Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: Implications for pre‐mRNA processingMolecular Carcinogenesis, 2004
- Quantitative proteomic analysis of Myc oncoprotein functionThe EMBO Journal, 2002
- Temporally Distinctive Changes of Alternative Splicing Patterns during Myogenic Differentiation of C2C12 CellsThe Journal of Biochemistry, 1995
- On the Origin of Cancer CellsScience, 1956